Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024

Rhea-AI Summary

Allurion Technologies, Inc. (NYSE: ALUR), a company focused on ending obesity, has announced that it will release its second quarter 2024 financial results on Tuesday, August 13, 2024. The company will host a conference call and live audio webcast on the same day at 8:30 AM ET to discuss the results and provide a business update.

Investors can access the conference call by dialing (888) 330-3417 (domestic) or +1 646 960 0804 (international) using Conference ID 1905455. The live audio webcast will be available on the Events section of Allurion's Investor Relations website. A replay of the call will be accessible by phone using Access Code 1905455, and the archived webcast will be available on the company's website.

NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it will report financial results for the second quarter 2024 on Tuesday, August 13, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET.

To access the conference call by telephone, please dial (888) 330-3417 (domestic) or +1 646 960 0804 (international) and use Conference ID 1905455. To listen to the conference call via live audio webcast, please visit the Events section of Allurion’s Investor Relations website at Allurion - Events & Presentations.

A replay of the conference call will be available by telephone by dialing (800) 770 2030 and using Access Code 1905455. The archived webcast will also be available on Allurion’s Investor Relations website mentioned above.

About Allurion

Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that features the Allurion Gastric Balloon, the world’s first and only swallowable, Procedureless™ intragastric balloon for weight loss, and offers access to the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Coach Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States.

For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.

Allurion is a trademark of Allurion Technologies, Inc. in the United States and countries around the world.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240716887108/en/

Global Media

Cedric Damour

PR Manager

+33 7 84 21 02 20

cdamour@allurion.com

Investor Contact

Mike Cavanaugh, Investor Relations

ICR Westwicke

(617) 877-9641

mike.cavanaugh@westwicke.com

Source: Allurion Technologies, Inc.

FAQ

When will Allurion Technologies (NYSE: ALUR) report its Q2 2024 financial results?

Allurion Technologies (NYSE: ALUR) will report its second quarter 2024 financial results on Tuesday, August 13, 2024.

What time is Allurion's Q2 2024 earnings conference call scheduled for August 13, 2024?

Allurion's Q2 2024 earnings conference call is scheduled for 8:30 AM ET on August 13, 2024.

How can investors access Allurion's Q2 2024 earnings call on August 13, 2024?

Investors can access Allurion's Q2 2024 earnings call by dialing (888) 330-3417 (domestic) or +1 646 960 0804 (international) and using Conference ID 1905455. A live audio webcast will also be available on Allurion's Investor Relations website.

Will there be a replay available for Allurion's Q2 2024 earnings call?

Yes, a replay of Allurion's Q2 2024 earnings call will be available by telephone by dialing (800) 770 2030 and using Access Code 1905455. The archived webcast will also be available on Allurion's Investor Relations website.